Terms: = Endocrine gland cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
13 results:
1. High Expression of CHST11 Correlates with Poor prognosis and Tumor Immune Infiltration of Pancreatic cancer.
Zhang P; Chen D; Cui H; Luo Q
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546737
[TBL] [Abstract] [Full Text] [Related]
2. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract] [Full Text] [Related]
4. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Sep; 15(9):2491-2503. PubMed ID: 33690968
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
Wu D; Wang X; Shi G; Sun H; Ge G
Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
[TBL] [Abstract] [Full Text] [Related]
6. Hospital Surgical Volume and 3-Year Mortality in Severe prognosis cancers: A Population-Based Study Using cancer Registry Data.
Taniyama Y; Tabuchi T; Ohno Y; Morishima T; Okawa S; Koyama S; Miyashiro I
J Epidemiol; 2021 Jan; 31(1):52-58. PubMed ID: 31932528
[TBL] [Abstract] [Full Text] [Related]
7. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis.
Ruiz J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):317-325. PubMed ID: 31882257
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
Park H; Bang JH; Nam AR; Park JE; Jin MH; Bang YJ; Oh DY
Cancer Med; 2020 Jan; 9(1):43-51. PubMed ID: 31701645
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract] [Full Text] [Related]
10. Impact of S100A4 Expression on Clinicopathological Characteristics and prognosis in Pancreatic cancer: A Meta-Analysis.
Huang S; Zheng J; Huang Y; Song L; Yin Y; Ou D; He S; Chen X; Ouyang X
Dis Markers; 2016; 2016():8137378. PubMed ID: 26903691
[TBL] [Abstract] [Full Text] [Related]
11. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract] [Full Text] [Related]
12. Adrenocortical carcinoma: diagnosis, evaluation and treatment.
Ng L; Libertino JM
J Urol; 2003 Jan; 169(1):5-11. PubMed ID: 12478091
[TBL] [Abstract] [Full Text] [Related]
13. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
[TBL] [Abstract] [Full Text] [Related]
